BioCentury
ARTICLE | Company News

Lantibio, TRB Chemedica, Alcon Laboratories Inc. deal

November 12, 2007 8:00 AM UTC

Lantibio and TRB granted Alcon exclusive U.S. rights to commercialize Vismed to treat dry eye syndrome. The aqueous solution of sodium hyaluronate is in Phase III testing for the indication. Lantibio...